Global Neurovascular Devices Market Forecast to 2027
The Neurovascular Devices Market is forecasted to grow from USD 2.12 Billion in 2018 to USD 3.35 Billion by 2026, at a CAGR of 5.6%, during the forecast period. The market is primarily driven by the growing target population for patients, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets, and increased market demand for effective neurovascular devices. Neurovascular therapy technological developments, such as the development of GORE TIGRIS by W L Gore and Medtronic distal filter embolic protection device SpiderFX, are expected to serve as a high impact rendering driver. It is expected that inclination for minimally invasive surgery in brain aneurysm and stroke treatments will be the key factor that will increase market growth.
The report also covers the impact of the COVID-19 pandemic on the Neurovascular Devices market and major segments. The pandemic has affected every industry vertical either positively or negatively. The report discusses in detail the changes in the demands and trends and the major challenges of the market created due to the pandemic. The report also offers a thorough current and future analysis of the impact of the COVID-19 pandemic on the overall growth of the market.
To get a sample PDF copy of the report, visit @ https://www.reportsanddata.com/sample-enquiry-form/1348
The report presents a panoramic view of the competitive landscape of the Neurovascular Devices market, covering details about the key manufacturers and companies, price analysis, revenue estimation, gross profit margins, business expansion plans, and other vital details that offers the readers deep insights into each company operating in the industry. The report also focuses on strategic alliances in the Neurovascular Devices market, such as mergers and acquisitions, joint ventures, product launches, brand promotions, collaborations, licensing agreements, partnerships, corporate and government deals, and others.
Top Players Analyzed in the Report are:
- L. Gore & Associates, Inc. (US), Terumo Corp. (Japan), Abbott Laboratories (US), Merit Medical Systems, Inc. (US), Medtronic Plc (Ireland), Penumbra, Inc. (US), Stryker Corp. (US), Johnson & Johnson (US), MicroPort Scientific Corp. (China) and others.
Product Type Segmentation:
Cerebral Embolization and Aneurysm Coiling
Cerebral Angioplasty and Stenting Systems
Neurothrombectomy
Support
Application Segmentation:
Cerebral Artery Stenosis
Stroke
Cerebral Aneurysm
Others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1348
Regional Analysis Covers:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
For a comprehensive value chain analysis, the report covers the downstream and upstream essentials of the Neurovascular Devices market. It also pays special focus on the growth process, macro- and micro-economic factors, raw material sources analysis, and other technical data. The report further segments the market on the basis of types, applications, and regions and offers insights into the segments that have the highest penetration and profit margin, along with recent developments based on geographies.
Benefits of Global Neurovascular Devices Market Report:
- Comprehensive analysis of the changing market dynamics
- A futuristic outlook on different factors influencing the market
- An 8-year forecast of the market growth and expected revenue growth
- Ease of understanding of the market, key segments, and their future growth
- In-depth analysis of the competitive landscape to give an advantageous edge for the companies
- Extensive insight into the market with in-depth analysis of the segmentation
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/neurovascular-devices-market
Thank you for reading our report. For further queries or inquiries about customization, kindly connect with us to know more. Our team will ensure the report is tailored according to your needs.
Contact Us:
John Watson
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: [email protected]
